Shilpa Medicare Ltd. has received approval from MHRA, UK, for Betahistine Dihydrochloride Orodispersible Films, 24 mg, making it the first company to receive approval for this strength in the UK. This approval is for a prescription Oral Film product manufactured at the companys facility in Bengaluru, Karnataka.